Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02066298 · ClinicalTrials.gov registry record · Phase 3
Steroids In Eosinophil Negative Asthma
A Phase 3 study, sponsored by Milton S. Hershey Medical Center.
- Completed
- Registry status
- Phase 3
- Development phase
- 295
- Enrollment target
NCT02066298 is a Phase 3 study that has completed, run by Milton S. Hershey Medical Center. The registered enrollment target is 295 participants.
The verdict
NCT02066298, a Phase 3 study, has completed, sponsored by Milton S. Hershey Medical Center.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 295 participants
- Enrollment target
Study Summary
Because approximately half of all mild-moderately-severe asthma is persistently non-eosinophilic, it is important to determine prospectively if patients who are persistently non-eosinophilic differ in their benefit from inhaled corticosteroid treatment compared to patients who are not persistently non-eosinophilic.
Interventions
- DRUG Placebo
- DRUG Mometasone 220mcg BID
- DRUG Tiotropium Respimat 5mcg QD
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 295 participants |
| Start Date | 2014-07 |
| Est. Completion | 2018-05 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02066298
The ClinicalTrials.gov registry entry for NCT02066298 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 295 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Milton S. Hershey Medical Center, which has 396 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT02066298 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02066298 about?
NCT02066298 is a clinical study titled "Steroids In Eosinophil Negative Asthma". Because approximately half of all mild-moderately-severe asthma is persistently non-eosinophilic, it is important to determine prospectively if patients who are persistently non-eosinophilic differ in their benefit from inhaled corticosteroid treatment compared to patients who are not persistently n...
What is the current status of trial NCT02066298?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 295 participants. The study started on 2014-07. Estimated completion is 2018-05.
What interventions are being tested in trial NCT02066298?
The interventions under investigation include: Placebo (DRUG), Mometasone 220mcg BID (DRUG), Tiotropium Respimat 5mcg QD (DRUG).
Who is sponsoring clinical trial NCT02066298?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.